AbbVie to Present at the Evercore ISI Conference and Piper Sandler Healthcare Conference
NORTH CHICAGO, Ill., Nov. 24, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) will participate in the Evercore ISI Virtual HealthCONx Conference
Read moreAbbVie
AbbVie is an American publicly-traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
AbbVie Announces Expiration and Final Results of Registered Exchange Offers
NORTH CHICAGO, Ill., Nov. 18, 2020 /PRNewswire/ — AbbVie Inc. (NYSE:ABBV) (“AbbVie“) announced today the expiration and final results of
Read moreAllergan Aesthetics Celebrates Second Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day
IRVINE, Calif., Nov. 16, 2020 /PRNewswire/ — Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating its second annual BOTOX® Cosmetic
Read moreNew Alliance to Address Multiple Pain Points for Women Living with Endometriosis
Washington, D.C., Nov. 16, 2020 (PR NEWSWIRE) – Today, seven women’s health-focused organizations – the American College of Obstetricians and Gynecologists (ACOG), the Endometriosis
Read moreAbbVie to Present at the Wolfe Research Healthcare Conference
NORTH CHICAGO, Ill., Nov. 12, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) will participate in the Wolfe Research Healthcare Conference on
Read moreAllergan, an AbbVie company, to Share New Data at American Academy of Ophthalmology (AAO) 2020 Virtual
NORTH CHICAGO, Ill., Nov. 6, 2020 – Allergan, an AbbVie Company, today announced that it will present new data advancing
Read moreAbbVie to Highlight Blood Cancer Leadership and Advancing Oncology Pipeline at the ASH 62ND Annual Meeting
NORTH CHICAGO, Ill., Nov. 5, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) announced that it will present blood cancer data from nearly
Read moreAbbVie Reports Third-Quarter 2020 Financial Results
NORTH CHICAGO, Ill., Oct. 30, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) announced financial results for the third quarter ended September 30, 2020.
Read moreAbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ™ (upadacitinib) in Atopic Dermatitis
NORTH CHICAGO, Ill., Oct. 29, 2020 /PRNewswire/ — Late-breaking data analyses to be presented by AbbVie (NYSE: ABBV) at the 29th
Read moreAbbVie Highlights Innovative Research for People with Rheumatic Diseases with New Data at ACR Convergence 2020
NORTH CHICAGO, Ill., Oct. 28, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the presentation
Read moreAllergan, an AbbVie Company, Announces Positive Phase 3 Topline Results for Investigational AGN-190584 for the Treatment of Presbyopia
NORTH CHICAGO, Ill., Oct. 28, 2020 /PRNewswire/ — Allergan, an AbbVie (NYSE: ABBV) company, today announced the Phase 3 GEMINI 1
Read moreAbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) in Atopic Dermatitis
NORTH CHICAGO, Ill., Oct. 19, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that it has submitted applications to the U.S.
Read moreAbbVie Announces Commencement of Registered Exchange Offers
NORTH CHICAGO, Ill., Oct. 19, 2020 /PRNewswire/ — (“AbbVie”) announced today the commencement of its offers to exchange (the “Registered Exchange
Read moreVENCLEXTA® (venetoclax) Receives FDA Full Approval for Acute Myeloid Leukemia (AML)
NORTH CHICAGO, Ill., Oct. 16, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration
Read moreAllergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting
IRVINE, Calif., Oct. 9, 2020 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that it will present
Read moreAllergan, an AbbVie Company, and Von Miller Encourage People with Glaucoma to Design Their Disease Management Plan
NORTH CHICAGO, Ill., Oct. 8, 2020 /PRNewswire/ — More than 4 million people in the United States are expected to
Read moreAllergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business
IRVINE, Calif., Oct. 7, 2020 /PRNewswire/ — Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that it has entered into an
Read moreAbbVie to Host Third-Quarter 2020 Earnings Conference Call
NORTH CHICAGO, Ill., Oct. 6, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) will announce its third-quarter 2020 financial results on Friday,
Read moreAbbVie to Present New Data From 15 Abstracts at the 2020 Virtual Migraine Trust International Symposium
NORTH CHICAGO, Ill., Oct. 2, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced it will present results from several clinical
Read moreSkinMedica® Launches TNS® Advanced+ Pro-Infusion Serum for DiamondGlow™
IRVINE, Calif., Sept. 30, 2020 /PRNewswire/ — Today Allergan Aesthetics, an AbbVie company, announced the launch of SkinMedica® TNS® Advanced+ Pro-Infusion Serum for
Read moreAbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
NORTH CHICAGO, Ill., Sept. 28, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration
Read moreVoting for the 2020 AbbVie CF Scholarship Thriving Student Awards is Open to the Public Until September 30
NORTH CHICAGO, Ill., Sept. 16, 2020 /PRNewswire/ — AbbVie today announced the start of its annual public voting period for the
Read moreMalin Akerman Joins CoolSculpting® and CoolTone™ as U.S. Ambassador for the Allergan Aesthetics Body Contouring Portfolio
IRVINE, Calif., Sept. 16, 2020 /PRNewswire/ — Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the partnership between actress
Read moreAllergan Aesthetics and Skinbetter Science Announce The DREAM Initiative™ To Advance Health Equity and Diversity in Aesthetics
IRVINE, Calif. and PHOENIX, Sept. 14, 2020 /PRNewswire/ — Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), and Skinbetter Science®
Read moreAbbVie to Present New Data From 18 Abstracts at the International Congress of Parkinson’s Disease and Movement Disorders®
NORTH CHICAGO, Ill., Sept. 11, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced it will present results from several studies,
Read more